Mannkind's Insulin Inhaler Receives FDA Approval

June 28, 2014 5:13 PM

14 0

The U.S. Food and Drug Administration has granted Mannkind Corp. clearance to sell Afrezza, a powder form of insulin created for controlling blood sugar levels in people with diabetes.

The U.S. Food and Drug Administration has granted Mannkind Corp. clearance to sell Afrezza, a powder form of insulin created for controlling blood sugar levels in people with diabetes.

Also read: Podcast: Ryan Tannehill is back. But is he better than ever?

Read more

To category page

Loading...